Intractable Coronavirus Disease 2019 (COVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication in a Chimeric Antigen Receptor-Modified T-Cell Therapy Recipient: A Case Study

A chimeric antigen receptor-modified T-cell therapy recipient developed severe coronavirus disease 2019, intractable RNAemia, and viral replication lasting >2 months. Premortem endotracheal aspirate contained >2 × 10(10) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA copies/m...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Infect Dis
Main Authors: Hensley, Matthew K, Bain, William G, Jacobs, Jana, Nambulli, Sham, Parikh, Urvi, Cillo, Anthony, Staines, Brittany, Heaps, Amy, Sobolewski, Michele D, Rennick, Linda J, Macatangay, Bernard J C, Klamar-Blain, Cynthia, Kitsios, Georgios D, Methé, Barbara, Somasundaram, Ashwin, Bruno, Tullia C, Cardello, Carly, Shan, Feng, Workman, Creg, Ray, Prabir, Ray, Anuradha, Lee, Janet, Sethi, Rahil, Schwarzmann, William E, Ladinsky, Mark S, Bjorkman, Pamela J, Vignali, Dario A, Duprex, W Paul, Agha, Mounzer E, Mellors, John W, McCormick, Kevin D, Morris, Alison, Haidar, Ghady
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2021
Assuntos:
Online Only Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7929077/
https://ncbi.nlm.nih.gov/pubmed/33507235
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciab072
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados